- ￥10700
- MATRiKs Biotek
- 土耳其
- INF-QNFT-REMI
- 2025年08月29日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
5
- 供应商：
西宝生物400-021-8158
- 规格：
96T
Enzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to infliximab in serum and plasma.
SHIKARI® Semi-Quantitative Free/Total Antibodies to Infliximab ELISA is a sandwich assay for the determination of total and free antibodies against infliximab in serum and plasma samples. During the first incubation period, the separation of infliximab specific antibody- infliximab immune complex is provided by adding dissociation buffer. After transferring dissociation mix to the plate, infliximab antibodies are separated from infliximab in patient serum/plasma samples and they are captured by the drug infliximab coated on the wall of the microtiter wells and horse radish peroxidase (HRP) conjugated probe. After washing away the unbound components from samples, the bound enzymatic activity is detected by addition of tetramethylbenzidine (TMB) chromogen substrate. Finally, the reaction is terminated with an acidic stop solution. The intensity of the reaction colour is directly proportional to the concentration of infliximab antibodies in sample.
This kit can be also used as a semi-quantitative test for free anti-drug antibodies determination without dissociation and neutralization steps.
Free and Total Anti drug Antibody monitoring gained high importance along with measuring free drug from the patient samples. In order to make these measurements simple yet more informative. We have produced SHIKARI® Q-ATI DUO to measure Free and Total anti drug antibodies to Infliximab simultaniously on the same plate. The kit is semi-quantitative and enables follow up of the patients to adjust the dose of the drug and/or frequency of administration
All SHIKARI® ELISA kits are suitable for biosimilar work.
All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验RNASafer® Protocol for Total RNA Isolation
2. Protocol for total RNA purification from culture cells and white blood cells with E.Z.N.A.® Total RNA System 1) For RNA isolation using RNA miniprep kit, take 150ul cell/RNASafer® Reagent mixture to a RNase free 1.5 ml tube. Add 200ul TRK lysis
E.Z.N.A.® Total RNA Midi Kit Protocol for Eukaryotic Cells and Tissues
实验原理 The E.Z.N.A. Total RNA Midiprep Kits use the reversible binding properties of HiBind® matrix, a new silica-based material. This is combined with the speed of mini-column spin technology. A specifically formulated high
E.Z.N.A.® HP Total RNA Kit Spin Protocol Eukaryotic Cells and Tissues
实验原理 The E.Z.N.A.® HP Total RNA Kit uses the reversible binding properties of HiBind® matrix, a new silica-based material. This is combined with the speed of mini-column spin technology. A specifically formulated high salt
技术资料暂无技术资料 索取技术资料
